Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
about
Ductal approaches to assessment and management of women at high risk for developing breast cancerBreast cancer preventionHas tamoxifen had its day?The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesionsFuture possibilities in the prevention of breast cancer: breast cancer prevention trials.Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention.Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers.Optimal delivery of male breast cancer follow-up care: improving outcomesFactors affecting uptake and adherence to breast cancer chemoprevention: a systematic review and meta-analysisMolecular cancer prevention: Current status and future directionsMain controversies in breast cancerExemestane for breast cancer prevention: a critical shift?Breast cancer chemoprevention: progress and controversy.Physician and Patient Barriers to Breast Cancer Preventive TherapyMedical prevention of breast cancerFamiliar drugs may prevent cancerChemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast CancerFirst do no harm: extending the debate on the provision of preventive tamoxifenPrevention of breast cancer in postmenopausal women: approaches to estimating and reducing riskAtypical hyperplasia of the breast--risk assessment and management options.Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction.Update in internal medicine.Current strategies for the prevention of breast cancerBreast cancer treatment and chemoprevention.Current status of tamoxifen use: An update for the surgical oncologist.The 1999 James Ewing Lecture: in pursuit of molecules of oncogenesis and neoplastic therapy.Effect of SERMs on breast tissue.Tolerability profile of SERMs.Tamoxifen prevention of breast cancer: an instance of the fingerpost.Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.Preventing heart disease and cancer. What randomized, primary-prevention studies show.The complexities of predictive genetic testingGuidelines for monitoring patients taking tamoxifen treatment.Tamoxifen for the prevention of breast cancer in the high-risk woman.Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancerManagement of familial breast cancer risk.Chemoprevention of breast cancer by tamoxifen: risks and opportunities.Pharmacology and clinical experience with exemestane.Breast cancer prevention trials.
P2860
Q24794407-DC657D58-9C96-40DF-BEC9-7DED2F64E97EQ24797803-2EBA8026-852B-42D2-9D6C-5536C71617AAQ24800161-3E664B9B-92CB-4FCD-A44B-2DE35CCBA563Q24802837-7EA237C3-0B8E-4834-9260-2F5254789972Q24803259-13EA84CA-2CAA-4074-AB03-6AE0C1646A31Q24803327-733F7C40-6A0F-4BA2-8084-EE80EAA2C900Q24803349-D9A6462A-BBB5-469D-BDE0-1B7A5EC904A8Q26773195-9A892720-F955-4F2A-999D-D8325A17427DQ26773464-F9EE65CC-2F91-4C57-8E25-55AC85CCE42BQ26797207-8C185154-B950-4EB0-ABEA-691F8D6FEFABQ27026673-395916F0-F400-489C-B3F8-78B540C3571BQ27028211-72C872D8-F6D4-49E5-8A46-B2C4B988E963Q27692587-F5D1AC37-F9DC-4B88-9161-74BB8146CA7CQ28072526-2F4BE91D-2661-41FE-A26E-A3534EDCE4DCQ28086915-F36FA98E-8BFB-4940-9C13-84F0C1C90DC1Q28186835-30540236-7EA0-440E-A31F-B1E8562B14ADQ28343780-43BDD964-528F-4947-B7AA-1A9A409E1AB4Q28365007-FDE1E190-0127-40D8-8BD1-BF53D82C778FQ28390064-4859DA0C-A6B2-4B7D-9035-859C2E1EC79FQ30301033-89A77B6E-D089-4CC1-83E3-1E698601F8F2Q30620889-E516FE03-8CE9-47FA-BF03-5EAB66EEFCFEQ30936399-2FC19E08-DDCA-43D8-8474-9C299B5477D7Q33588350-6246AAB1-7C86-4995-8FFF-24BB9C5DE43EQ33599463-B4539CDE-3A6B-4BA8-BA09-82955010DC0FQ33720741-33F9F004-2FCE-4408-9BDE-C48C7756CEC8Q33729025-095C8D41-6B2B-449B-B529-062FDBEB11DCQ33736502-391431AB-3840-4046-86D4-DD55BBD2AC47Q33757750-FDA127A9-B4E4-4F84-8DB1-FD4D8A895BE1Q33757754-53928191-BF95-4CB4-8F10-88DBC36F9323Q33765698-AB603764-B34F-40B1-B374-141118C7FC4BQ33765709-169773B8-7B12-4EFC-9FD9-0E52011B2503Q33772822-B75F40AF-D285-4BBC-99C2-6A87916B6FADQ33805238-6B82CE64-AE28-4D22-87E3-620905472CE6Q33824823-83C4D16E-4E54-4969-9BDF-701209B54DC0Q33837654-3BDFC770-A9C2-4FB2-923F-86794F1CA097Q33965106-182E9C4A-3DBA-491C-A624-2276E1475C56Q34034858-943E5FFB-B37A-4900-A3D2-59212EB373D4Q34072601-B1C88C8C-23F2-4416-82CA-370E08638990Q34075034-3DA2E3AD-D355-4CDB-B1BE-0E8C04641DB9Q34108126-965C2594-91E9-407E-9DE0-554D25ADDD42
P2860
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Interim analysis of the incide ...... ndomised chemoprevention trial
@ast
Interim analysis of the incide ...... ndomised chemoprevention trial
@en
Interim analysis of the incide ...... ndomised chemoprevention trial
@nl
type
label
Interim analysis of the incide ...... ndomised chemoprevention trial
@ast
Interim analysis of the incide ...... ndomised chemoprevention trial
@en
Interim analysis of the incide ...... ndomised chemoprevention trial
@nl
prefLabel
Interim analysis of the incide ...... ndomised chemoprevention trial
@ast
Interim analysis of the incide ...... ndomised chemoprevention trial
@en
Interim analysis of the incide ...... ndomised chemoprevention trial
@nl
P2093
P3181
P1433
P1476
Interim analysis of the incide ...... ndomised chemoprevention trial
@en
P2093
P304
P3181
P356
10.1016/S0140-6736(98)85012-5
P407
P577
1998-07-11T00:00:00Z